Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12615001174572
Ethics application status
Approved
Date submitted
28/10/2015
Date registered
2/11/2015
Date last updated
9/12/2016
Type of registration
Prospectively registered

Titles & IDs
Public title
Feasibility Study of a Brief Telephone-based Cannabis Intervention
Scientific title
A brief telephone-based intervention for treatment seeking cannabis users with the primary outcome of cannabis use frequency
Secondary ID [1] 287739 0
None
Universal Trial Number (UTN)
U1111-1175-8732
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cannabis Use Disorder 296602 0
Condition category
Condition code
Mental Health 296866 296866 0 0
Addiction

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Brief (60 minute) one session telephone-based intervention based on motivational interviewing and cognitive behavioural therapies. This call will be made by the counsellors working at the Cannabis Information Helpline who will receive intervention training. In addition to this training, adherence will be monitoring by the Helpline supervisors as well as by research staff who will listen to approximately 20% of the sessions.
Intervention code [1] 293136 0
Behaviour
Intervention code [2] 293149 0
Lifestyle
Comparator / control treatment
Do-It-Yourself workbooklet on reducing cannabis use
Control group
Active

Outcomes
Primary outcome [1] 296454 0
Frequency of cannabis use assessed by telephone interview with research staff
Timepoint [1] 296454 0
Three month follow-up
Secondary outcome [1] 318484 0
Cannabis-related problems assessed by telephone interview with research staff
Timepoint [1] 318484 0
Three month follow-up
Secondary outcome [2] 318485 0
Severity of cannabis dependence assessed by telephone interview with research staff
Timepoint [2] 318485 0
Three month follow-up

Eligibility
Key inclusion criteria
18+ Years of age
Recent cannabis use
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Unable to give informed consent (no mental health concerns)
Dependence on other illicit substances
Recent cannabis use treatment

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The researcher who determined if a subject was eligible for inclusion in the trial was unaware, when this decision was made, to which group the subject would be allocated. Allocation assignment will be determined after screening for inclusion criteria and gaining consent through central randomisation by computer software which will present the outcome one at a time when activated.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
The quantitative and qualitative data in this study will be analyzed using IBM SPSS Statistics, Release Version 22.
To address the study aim of determining whether intervention participants show a greater reduction in treatment outcome measures compared to the control group, an independent structure, linear model, Generalised Estimating Equation (GEE) approach to repeated measures analysis will be used to test between-group differences. GEE is appropriate for measuring the relationship between outcome variables and corresponding predictor variables over time. Prior to longitudinal modelling, two-tailed bivariate zero-order correlation analyses will be conducted between the treatment outcome variables and an indicator for the presence of any external cannabis treatment or pharmaceutical medication (dichotomous items that will be recorded at baseline and follow-up assessments). In the case of a statistically significant association, these indicator variables will be included into analyses as covariates. Similarly, to determine which baseline participant characteristics were associated with variance in cannabis-related treatment outcomes, a second series of two-tailed bivariate zero-order correlation analyses will be conducted. Due to an expected large number of comparisons for these analyses, Bonferroni corrections will be made to control for the probability of false positive findings. Finally, participant drop out in follow-up assessments will be tested prior to analysis to determine that the relevant data was missing completely at random (MCAR) using Little’s MCAR test.

As this is a pilot feasibility trial, a power analysis was not performed to determine sample size. Instead, the expected number of participants (n=100) was determined (based on the call rate to the Helpline and the project timeline) to allow for an assumed uptake of approximately 15%.

Recruitment
Recruitment status
Stopped early
Data analysis
Data analysis is complete
Reason for early stopping/withdrawal
Participant recruitment difficulties
Date of first participant enrolment
Anticipated
30/11/2015
Actual
7/12/2015
Date of last participant enrolment
Anticipated
30/04/2016
Actual
30/06/2016
Date of last data collection
Anticipated
Actual
30/09/2016
Sample size
Target
100
Accrual to date
Final
19
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 292283 0
Government body
Name [1] 292283 0
Government Department of Health
Country [1] 292283 0
Australia
Primary sponsor type
Individual
Name
Peter Gates
Address
UNSW Randwick Campus NDARC
Building R1 Level 1, 22-32 King St
Randwick NSW 2031, Australia
Country
Australia
Secondary sponsor category [1] 290967 0
None
Name [1] 290967 0
Address [1] 290967 0
Country [1] 290967 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 293756 0
University of NSW HREC
Ethics committee address [1] 293756 0
Ethics committee country [1] 293756 0
Australia
Date submitted for ethics approval [1] 293756 0
01/12/2015
Approval date [1] 293756 0
03/12/2015
Ethics approval number [1] 293756 0
HC15744

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 61190 0
Dr Peter Gates
Address 61190 0
UNSW Randwick Campus NDARC
Building R1 Level 1, 22-32 King St
Randwick NSW 2031Australia
Country 61190 0
Australia
Phone 61190 0
+61293850269
Fax 61190 0
+61293850201
Email 61190 0
[email protected]
Contact person for public queries
Name 61191 0
Peter Gates
Address 61191 0
UNSW Randwick Campus NDARC
Building R1 Level 1, 22-32 King St
Randwick NSW 2031Australia
Country 61191 0
Australia
Phone 61191 0
+61293850269
Fax 61191 0
+61293850201
Email 61191 0
[email protected]
Contact person for scientific queries
Name 61192 0
Peter Gates
Address 61192 0
UNSW Randwick Campus NDARC
Building R1 Level 1, 22-32 King St
Randwick NSW 2031Australia
Country 61192 0
Australia
Phone 61192 0
+61293850269
Fax 61192 0
+61293850201
Email 61192 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.